Effect of anti-oxidant agents in patients with hepatocellular diseases

Eur Rev Med Pharmacol Sci. 2015 Nov;19(21):3993-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Humans
  • Male
  • Non-alcoholic Fatty Liver Disease / drug therapy*
  • Silymarin / administration & dosage*
  • Vitamin E / administration & dosage*

Substances

  • Silymarin
  • Vitamin E